8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer)
Published . Updated .
8-K - Eloxx Pharmaceuticals filed an 8-K with the SEC on Oct 22 (a notice of a material company event).
Directly affected
- ELOX Eloxx Pharmaceuticals
Named in this report.
Indirectly affected
- SPY SPDR S&P 500+1.6%
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond-1.8%
Long-term U.S. government bonds
- QQQ Invesco QQQ+2.3%
Large technology stocks
- GLD SPDR Gold Shares-3.3%
Gold can move with the broad market
Price reaction, T-5 to T+3
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-22 AccNo: 0001193125-26-428116 Size: 146 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events
Source: sec-edgar
Eloxx Pharmaceuticals (ELOX) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Eloxx Pharmaceuticals (ELOX) | that day | 0.00% | still updating |
| Eloxx Pharmaceuticals (ELOX) | three days earlier | -3.59% | final price |
| Eloxx Pharmaceuticals (ELOX) | five days earlier | -0.04% | final price |
| GLD | that day | -1.95% | still updating |
| GLD | three days earlier | +0.18% | final price |
| GLD | five days earlier | +0.98% | final price |
| QQQ | that day | -1.45% | still updating |
| QQQ | three days earlier | -0.96% | final price |
| QQQ | five days earlier | +0.41% | final price |
| SPY | that day | -0.74% | still updating |
| SPY | three days earlier | -0.84% | final price |
| SPY | five days earlier | -0.18% | final price |
| TLT | that day | +1.08% | still updating |
| TLT | three days earlier | -0.97% | final price |
| TLT | five days earlier | -0.31% | final price |
Who is named in “8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer)”
Companies tied to this story
- ELOX Eloxx Pharmaceuticals
Eloxx Pharmaceuticals (ELOX) is linked, with no stored direction, high confidence in the 22 Oct 2026 story “8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> ELOX
How “8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer)” reaches Eloxx Pharmaceuticals (ELOX)
On 22 Oct 2026, “8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer)” is the story that connects Eloxx Pharmaceuticals (ELOX) to this story.
Eloxx Pharmaceuticals (ELOX) is on the page because SEC 8-K filing -> direct issuer disclosure -> ELOX
Dates in the story, and the Eloxx Pharmaceuticals (ELOX) price range
ELOX traded between 13.31 and 13.51 across 1 sessions. The latest close on file is 13.36.
What the saved facts support for Eloxx Pharmaceuticals (ELOX)
16 out of 100Price not final
“8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer)” scores 16 out of 100. The score uses 1 sources, a +0.74% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.